NuraPlex U.S. launch
This article was originally published in The Tan Sheet
Eight multi-nutrient supplements for cancer patients that help "optimize health" during radiation and chemotherapy will launch in U.S. in February under the NuraPlex brand, AustCancer announces Oct. 17. Products initially will be available through health care professionals; the firm currently is in negotiations with a supermarket retailer in the Northeast. AustCancer expects NuraPlex products to be cash-flow positive within 12 months of launch...
You may also be interested in...
The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine.
Despite the turbulence of 2020 and the pressures of the coronavirus pandemic, Sandoz has reported steady sales for the year, as biopharmaceuticals sales up by a fifth offset a slide in turnover from retail generics.
Moderna is speculated to be in talks with Indian firms, including Wockhardt and a Tata group company, for manufacturing its COVID-19 vaccine. A deal in India could help the company meet its obligation to supply COVAX but Moderna is likely to choose its partner carefully.